How do I set up a LIMS for managing study samples and traceability across preclinical to clinical development?

Setting up a LIMS for study sample management and traceability across preclinical to clinical development is mostly about designing the sample lifecycle, data model, and audit trail before choosing/configuring the software.

Here’s a practical way to approach it.

---

1) Define the scope and use cases first

Map the end-to-end processes you need to support.

Typical scope

• Preclinical
  • in vivo / in vitro study samples
  • animal ID linkage
  • timepoints, dose groups, matrices, chain of custody
• Translational / bioanalysis
  • sample accessioning
  • aliquoting / pooling / rework
  • shipping and receipt
  • storage locations and freezer monitoring
  • assay prep and results capture
• Clinical
  • subject/sample coding and de-identification
  • visit/timepoint/sample collection
  • central lab or site lab workflows
  • specimen chain of custody and reconciliation
• Cross-cutting
  • inventory
  • protocol/amendment handling
  • deviations / exceptions
  • reporting and audit trail

Key question

What must be traceable? Usually:

• study → subject/animal → collection event → primary sample → aliquot → derivative → assay result → report
• plus who handled it, when, where, and under what condition

---

2) Define the core traceability model

A good LIMS for this purpose should enforce hierarchical relationships.

Recommended entity hierarchy

• Program
• Study
• Protocol version / amendment
• Subject / animal / donor
• Visit / timepoint / collection event
• Sample
• Aliquot / derivative
• Container
• Location
• Shipment
• Assay / test / run
• Result
• Document / attachment

Unique identifiers

Use stable IDs at each level:

• Study ID
• Subject ID
• Sample ID
• Aliquot ID
• Container ID
• Shipment ID
• Result ID

Best practice:

• generate IDs automatically
• never reuse IDs
• keep human-readable labels separate from system IDs

Chain-of-custody fields

Track for every sample movement:

• action type: collected, received, aliquoted, shipped, thawed, tested, destroyed
• timestamp
• user
• from location / to location
• reason / deviation code
• condition metadata: temperature, freeze/thaw count, hold time

---

3) Decide which workflows must be system-controlled

Do not try to automate everything at once. Start with the highest-risk workflows.

Usually highest priority

1. Accessioning
   • registering samples into the system
   • barcode assignment
   • label printing
2. Inventory and storage
   • freezer/rack/box/tube level tracking
3. Sample lifecycle
   • receive → store → aliquot → ship → test → archive/dispose
4. Study/sample-to-result traceability
   • link back from assay result to original sample and study
5. Audit trail and electronic signatures
   • immutable history of changes and approvals

---

4) Build the data model around regulatory needs

Even if this is not a formal GxP system, design it as if it will be audited.

Must-have compliance features

• Audit trail
  • every create/update/delete action logged
  • old and new values preserved
• Role-based access control
  • study manager, lab tech, QA, admin, reviewer
• Electronic signatures / approvals
  • if required
• Versioning
  • protocols, sample plans, assay methods, templates
• Data retention
  • configurable retention and archival policies
• Part 11 / Annex 11 readiness
  • if applicable to your environment

---

5) Standardize sample metadata

This is where many LIMS projects fail: too much inconsistency in sample naming and attributes.

Standard metadata to capture

• study ID
• protocol number/version
• subject/animal ID
• species/strain/sex/age for preclinical
• cohort/group/dose
• visit/timepoint
• matrix type
• collection date/time
• planned vs actual collection
• volume
• container type
• storage condition
• status
• parent sample ID
• derived from / pooled from
• test eligibility flags

Controlled vocabularies

Use dropdowns and reference tables for:

• sample type
• matrix
• collection method
• status
• deviation type
• shipment condition
• storage location type
• result unit

This reduces bad data and improves reporting.

---

6) Design barcoding and label strategy early

Barcode strategy is critical for traceability.

Good practice

• barcode every sample, aliquot, and container
• support 1D and/or 2D DataMatrix codes
• print labels from the LIMS
• define label formats by sample type and container

Include on label

• unique ID
• study ID
• sample type
• collection timepoint or aliquot number
• barcode
• optional human-readable short text

Avoid

• encoding too much business logic into the barcode
• using meaningful IDs that change
• manual relabeling without audit trail

---

7) Integrate with instruments and other systems

A LIMS for development programs should not be isolated.

Common integrations

• EDC/clinical systems for subject/sample context
• CTMS for study metadata
• ELN for experiment context
• CDMS / bioanalysis systems for results
• Freezer/IoT monitoring for temperature events
• ERP / procurement for consumables
• QMS for deviations, CAPA, change control

Integration patterns

• API-based integration where possible
• file-based import/export for legacy systems
• scheduled sync for reference data
• event-driven updates for sample status changes

Key principle

Make one system the system of record for each data domain:

• LIMS = sample inventory and traceability
• EDC/CTMS = clinical subject and visit source
• ELN = experimental narrative
• CDS/analysis platform = derived data/results

---

8) Configure workflows instead of customizing code too early

If you’re using commercial LIMS software, configure:

• study templates
• sample collection templates
• accessioning rules
• storage hierarchy
• labeling rules
• acceptance criteria
• result workflows
• approval routing

Keep custom development limited to:

• integrations
• complex business rules
• special reports
• automated reconciliation

---

9) Plan for preclinical-to-clinical continuity

This is the “translational traceability” part.

Challenges

Preclinical and clinical often use different identifiers, sample types, and workflows.

How to handle it

• create a master study/program record that links related preclinical and clinical studies
• maintain cross-study mapping tables
• preserve parent-child lineage for samples
• define consistent metadata across phases where possible
• allow phase-specific fields without breaking common traceability

Example

• Program: ONC-123
• Preclinical study: ONC-123-GLP-01
• Clinical study: ONC-123-PH1-01
• common target biomarker panel
• shared analyte/result conventions
• linked specimen lineage and versioned assay methods

---

10) Implement inventory and location control

A real sample LIMS needs granular location management.

Location hierarchy

• site
• building
• room
• freezer
• shelf
• rack
• box
• position
• container

Inventory functions

• real-time sample location
• move logging
• reserved vs available status
• quarantine / hold / destroyed states
• temperature condition flags
• stock counts and reconciliation
• expiry and stability tracking

---

11) Build exception handling into the workflow

Traceability is not just about the ideal path.

Common exceptions

• mislabeled sample
• insufficient volume
• temperature excursion
• delayed shipment
• missing chain-of-custody
• collection deviation
• sample mix-up
• protocol amendment impact

System should support

• deviation logging
• impact assessment
• quarantine
• investigation record link
• approval for override or disposal

---

12) Reporting and traceability outputs

You’ll need reports that answer audit and operational questions quickly.

Essential reports

• sample lineage report
• chain-of-custody report
• study sample reconciliation
• inventory by location/status
• missing / overdue sample report
• stability / expiry report
• freezer excursion impact report
• subject-to-sample-to-result trace report
• audit trail export

Search capabilities

Users should be able to search by:

• study
• subject/animal
• sample ID
• barcode
• matrix
• date range
• location
• status
• assay
• result flag

---

13) Validate the system

Before go-live, validate against intended use.

Validation steps

• requirements specification
• configuration specification
• test scripts for critical workflows
• user acceptance testing
• traceability matrix
• security testing
• backup/restore testing
• audit trail review
• migration verification

If regulated, ensure validation is documented and approved.

---

14) Migrate legacy data carefully

Data migration is often the hardest part.

Strategy

• clean and standardize source data first
• define mapping for legacy IDs to new IDs
• import only high-quality historical data needed for traceability
• preserve original source values
• maintain migration audit logs
• verify sample counts and lineage after migration

Don’t

• overwrite source truth without archival
• migrate unstructured free-text without normalization
• import broken parent-child links without fixing them

---

15) Train users and define governance

System success depends on operational discipline.

Governance model

• system owner
• data owner
• QA/compliance
• lab ops lead
• IT/admin
• change control board

SOPs to create

• sample accessioning
• labeling
• storage and retrieval
• sample shipment/receipt
• deviation handling
• correction of data errors
• user access management
• periodic inventory reconciliation

---

16) Choose build vs buy carefully

Buy/configure if you need

• faster deployment
• audit/compliance features
• standard sample/inventory workflows
• established vendor support

Build if you need

• highly unique preclinical-to-clinical workflows
• deep custom integrations
• unusual sample lineage logic
• unified platform across many internal systems

Many organizations choose a commercial LIMS plus custom integrations.

---

Suggested implementation roadmap

Phase 1: Foundation

• define scope
• choose platform
• design data model
• set up roles, audit trail, IDs, labels

Phase 2: Core sample management

• accessioning
• inventory
• storage locations
• sample lifecycle
• basic reports

Phase 3: Study traceability

• study templates
• parent-child sample lineage
• subject/animal mapping
• shipment and receipt workflow

Phase 4: Clinical integration

• connect to EDC/CTMS
• de-identification handling
• reconciliation reports

Phase 5: Advanced controls

• deviation management
• freezer monitoring integration
• result integration
• approvals and electronic signatures

Phase 6: Validation and rollout

• UAT
• training
• SOPs
• phased deployment

---

A good target design in one sentence

A strong LIMS for this purpose is one that can trace every sample from origin to final disposition, across all study phases, with controlled identifiers, audit trail, inventory location, and linked results.

If you want, I can also provide:

1. a sample data model/schema,
2. a workflow diagram, or
3. a vendor selection checklist for LIMS platforms.